Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Wnt/β-catenin

Items 1-10 of 40

Page
per page
  1. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  2. Tankyrase Inhibitors (TNKS) 22
    A8600 Tankyrase Inhibitors (TNKS) 22
    Summary: Tankyrase inhibitor
  3. Tankyrase Inhibitors (TNKS) 49
    A8601 Tankyrase Inhibitors (TNKS) 49
    Target: Tankyrases
    Summary: Tankyrase inhibitor
      ≥22.45 mg/mL
  4. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  5. IWP-L6
    B2305 IWP-L6
    Summary: Porcupine inhibitor,highy potent
      ≥22.45 mg/mL
  6. LGK-974
    B2307 LGK-974
     1 Citation
    Summary: PORCN inhibitor,potent and specific
      insoluble in H2O; ≥19.8 mg/mL
  7. iCRT 14
    B4687 iCRT 14
    Summary: CRT inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.75 mg/mL
  8. QS 11
    B7364 QS 11
    Summary: ARFGAP1 inhibitor,Wnt/beta-catenin pathway modulator
      Soluble in DMSO
  9. PNU 74654
    B7422 PNU 74654
    Summary: Wnt signaling pathway inhibitor
      insoluble in H2O; insoluble in EtOH; ≥24.8 mg/mL
  10. Neurodazine
    B7457 Neurodazine
    Summary: Induces neurogenesis of non-pluripotent C2C12 myoblasts
      Soluble in DMSO

Items 1-10 of 40

Page
per page